These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38702077)

  • 41. Efficacy and safety of fosravuconazole L-lysine ethanolate, a novel oral triazole antifungal agent, for the treatment of onychomycosis: A multicenter, double-blind, randomized phase III study.
    Watanabe S; Tsubouchi I; Okubo A
    J Dermatol; 2018 Oct; 45(10):1151-1159. PubMed ID: 30156314
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of onychomycosis: a randomized, double-blind comparison study with topical bifonazole-urea ointment alone and in combination with short-duration oral griseofulvin.
    Friedman-Birnbaum R; Cohen A; Shemer A; Bitterman O; Bergman R; Stettendorf S
    Int J Dermatol; 1997 Jan; 36(1):67-9. PubMed ID: 9071624
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and safety of luliconazole 5% nail solution for the treatment of onychomycosis: A multicenter, double-blind, randomized phase III study.
    Watanabe S; Kishida H; Okubo A
    J Dermatol; 2017 Jul; 44(7):753-759. PubMed ID: 28332720
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Topical therapy for toenail onychomycosis: an evidence-based review.
    Gupta AK; Daigle D; Foley KA
    Am J Clin Dermatol; 2014 Dec; 15(6):489-502. PubMed ID: 25257931
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The efficacy and safety of efinaconazole 10% solution for treatment of mild to moderate onychomycosis: a pooled analysis of two phase 3 randomized trials.
    Gupta AK; Elewski BE; Sugarman JL; Ieda C; Kawabata H; Kang R; Pillai R; Olin JT; Watanabe S
    J Drugs Dermatol; 2014 Jul; 13(7):815-20. PubMed ID: 25007364
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and safety of a new medicated nail hydrolacquer in the treatment of adults with toenail onychomycosis: A randomised clinical trial.
    Zalacain-Vicuña AJ; Nieto C; Picas J; Martínez H; Bermejo R; Corrales A; Campos FF; Igea SA; Otero-Espinar FJ; Briones VG
    Mycoses; 2023 Jul; 66(7):566-575. PubMed ID: 36336989
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Susceptibility testing of amorolfine, bifonazole and ciclopiroxolamine against Trichophyton rubrum in an in vitro model of dermatophyte nail infection.
    Schaller M; Borelli C; Berger U; Walker B; Schmidt S; Weindl G; Jäckel A
    Med Mycol; 2009 Nov; 47(7):753-8. PubMed ID: 19888808
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The use of topical therapies to treat onychomycosis.
    Gupta AK; Ryder JE; Baran R
    Dermatol Clin; 2003 Jul; 21(3):481-9. PubMed ID: 12956200
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efinaconazole solution in the treatment of toenail onychomycosis: a phase 2, multicenter, randomized, double-blind study.
    Tschen EH; Bucko AD; Oizumi N; Kawabata H; Olin JT; Pillai R
    J Drugs Dermatol; 2013 Feb; 12(2):186-92. PubMed ID: 23377392
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pulse versus continuous terbinafine for onychomycosis: a randomized, double-blind, controlled trial.
    Warshaw EM; Fett DD; Bloomfield HE; Grill JP; Nelson DB; Quintero V; Carver SM; Zielke GR; Lederle FA
    J Am Acad Dermatol; 2005 Oct; 53(4):578-84. PubMed ID: 16198776
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Onychomycosis does not always require systemic treatment for cure: a trial using topical therapy.
    Friedlander SF; Chan YC; Chan YH; Eichenfield LF
    Pediatr Dermatol; 2013; 30(3):316-22. PubMed ID: 23278851
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative Study of Traditional Ablative CO
    Rajbanshi B; Shen L; Jiang M; Gao Q; Huang X; Ma J; Wang J; Hu Y; Lv H; Wu X; Zhao J
    Clin Drug Investig; 2020 Jun; 40(6):575-582. PubMed ID: 32314298
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Daily Application of an Aqueous, Acidifying, Peelable Nail Polish versus Weekly Amorolfine for Topical Onychomycosis Treatment: A Prospective, Randomized, Blinded Trial.
    Eertmans F; Doss N; Rossel B; Adriaens E
    Dermatol Ther (Heidelb); 2018 Sep; 8(3):463-473. PubMed ID: 30051298
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A randomized, double-blind trial of amorolfine 0.25% cream and sertaconazole 2% cream in limited dermatophytosis.
    Das A; Sil A; Sarkar TK; Sen A; Chakravorty S; Sengupta M; Das A; Chandra S; Pal S; Bandyopadhyay D; Das NK
    Indian J Dermatol Venereol Leprol; 2019; 85(3):276-281. PubMed ID: 30409926
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Scytalidium hyalinum onychomycosis successfully treated with 5% amorolfine nail lacquer.
    Downs AM; Lear JT; Archer CB
    Br J Dermatol; 1999 Mar; 140(3):555. PubMed ID: 10233295
    [No Abstract]   [Full Text] [Related]  

  • 56. The use of the Er:YAG 2940nm laser associated with amorolfine lacquer in the treatment of onychomycosis.
    Morais OO; Costa IM; Gomes CM; Shinzato DH; Ayres GM; Cardoso RM
    An Bras Dermatol; 2013; 88(5):847-9. PubMed ID: 24173203
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ciclopirox nail lacquer for the treatment of onychomycosis: an open non-comparative study.
    Shemer A; Nathansohn N; Trau H; Amichai B; Grunwald MH
    J Dermatol; 2010 Feb; 37(2):137-9. PubMed ID: 20175847
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Determination of the subungual antifungal activity of amorolfine after 1 month's treatment in patients with onychomycosis: comparison of two nail lacquer formulations.
    Mensing H; Polak-Wyss A; Splanemann V
    Clin Exp Dermatol; 1992 Sep; 17 Suppl 1():29-32. PubMed ID: 1458661
    [No Abstract]   [Full Text] [Related]  

  • 59. Efficacy, safety and tolerability of an optimized avulsion technique with onyster® (40% urea ointment with plastic dressing) ointment compared to bifonazole-urea ointment for removal of the clinically infected nail in toenail onychomycosis: a randomized evaluator-blinded controlled study.
    Lahfa M; Bulai-Livideanu C; Baran R; Ortonne JP; Richert B; Tosti A; Piraccini BM; Szepietowski JC; Sibaud V; Coubetergues H; Voisard JJ; Paul C
    Dermatology; 2013; 226(1):5-12. PubMed ID: 23467055
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of onychomycosis by partial nail avulsion and topical miconazole.
    Rollman O
    Dermatologica; 1982 Jul; 165(1):54-61. PubMed ID: 6214436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.